| Cross-species genomics matches driver mutations and cell compartments to model ependymoma RA Johnson, KD Wright, H Poppleton, KM Mohankumar, D Finkelstein, ... Nature 466 (7306), 632-636, 2010 | 386 | 2010 |
| An autophagy assay reveals the ESCRT-III component CHMP2A as a regulator of phagophore closure Y Takahashi, H He, Z Tang, T Hattori, Y Liu, MM Young, JM Serfass, ... Nature communications 9 (1), 2855, 2018 | 295 | 2018 |
| An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymoma JM Atkinson, AA Shelat, AM Carcaboso, TA Kranenburg, LA Arnold, ... Cancer cell 20 (3), 384-399, 2011 | 125 | 2011 |
| Activating the Wnt/β-catenin pathway for the treatment of melanoma–application of ly2090314, a novel selective inhibitor of glycogen synthase kinase-3 JM Atkinson, KB Rank, Y Zeng, A Capen, V Yadav, JR Manro, TA Engler, ... PloS one 10 (4), 2015 | 104 | 2015 |
| Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer RJ Hartmaier, SE Trabucco, N Priedigkeit, JH Chung, CA Parachoniak, ... Annals of Oncology 29 (4), 872-880, 2018 | 103 | 2018 |
| Loss of function of NF1 is a mechanism of acquired resistance to endocrine therapy in lobular breast cancer ES Sokol, YX Feng, DX Jin, A Basudan, AV Lee, JM Atkinson, J Chen, ... Annals of Oncology 30 (1), 115-123, 2019 | 76 | 2019 |
| Development of a novel tumor-targeted vascular disrupting agent activated by membrane-type matrix metalloproteinases JM Atkinson, RA Falconer, DR Edwards, CJ Pennington, CS Siller, ... Cancer research 70 (17), 6902-6912, 2010 | 76 | 2010 |
| Tumour endoproteases: the cutting edge of cancer drug delivery? JM Atkinson, CS Siller, JH Gill British journal of pharmacology 153 (7), 1344-1352, 2008 | 71 | 2008 |
| Loss of E-cadherin Enhances IGF1–IGF1R Pathway Activation and Sensitizes Breast Cancers to Anti-IGF1R/InsR Inhibitors AM Nagle, KM Levine, N Tasdemir, JA Scott, K Burlbaugh, J Kehm, ... Clinical Cancer Research 24 (20), 5165-5177, 2018 | 68 | 2018 |
| Atg5-dependent autophagy contributes to the development of acute myeloid leukemia in an MLL-AF9-driven mouse model. WHG Liu Q, Chen L, Atkinson JM, Claxton DF Cell Death Dis 7 (9), 2016 | 67 | 2016 |
| Induction of store-operated calcium entry (SOCE) suppresses glioblastoma growth by inhibiting the Hippo pathway transcriptional coactivators YAP/TAZ Z Liu, Y Wei, L Zhang, PP Yee, M Johnson, X Zhang, M Gulley, ... Oncogene 38 (1), 120-139, 2019 | 66 | 2019 |
| Membrane type matrix metalloproteinases (MMPs) show differential expression in non-small cell lung cancer (NSCLC) compared to normal lung: correlation of MMP-14 mRNA expression … JM Atkinson, CJ Pennington, SW Martin, VA Anikin, AJ Mearns, ... European journal of cancer 43 (11), 1764-1771, 2007 | 66 | 2007 |
| Inhibiting aberrant signal transducer and activator of transcription protein activation with tetrapodal, small molecule Src homology 2 domain binders: promising agents against … BDG Page, DC Croucher, ZH Li, S Haftchenary, VH Jimenez-Zepeda, ... Journal of medicinal chemistry 56 (18), 7190-7200, 2013 | 40 | 2013 |
| ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation Z Li, O McGinn, Y Wu, A Bahreini, NM Priedigkeit, K Ding, S Onkar, ... Nature Communications 13 (1), 1-18, 2022 | 39 | 2022 |
| Single-cell transcriptomic heterogeneity in invasive ductal and lobular breast cancer cells F Chen, K Ding, N Priedigkeit, A Elangovan, KM Levine, N Carleton, ... Cancer Research 81 (2), 268-281, 2021 | 36 | 2021 |
| Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis Z Li, Y Wu, ME Yates, N Tasdemir, A Bahreini, J Chen, KM Levine, ... Cancer Research 82 (7), 1321-1339, 2022 | 34 | 2022 |
| Hotspot ESR1 mutations are multimodal and contextual modulators of breast cancer metastasis Z Li, Y Wu, ME Yates, N Tasdemir, A Bahreini, J Chen, KM Levine, ... Cancer Research, 2022 | 34 | 2022 |
| Tumor-targeted prodrug ICT2588 demonstrates therapeutic activity against solid tumors and reduced potential for cardiovascular toxicity JH Gill, PM Loadman, SD Shnyder, P Cooper, JM Atkinson, ... Molecular pharmaceutics 11 (4), 1294-1300, 2014 | 32 | 2014 |
| Endophilin B2 facilitates endosome maturation in response to growth factor stimulation, autophagy induction, and influenza A virus infection JM Serfass, Y Takahashi, Z Zhou, YI Kawasawa, Y Liu, N Tsotakos, ... Journal of Biological Chemistry 292 (24), 10097-10111, 2017 | 29 | 2017 |
| Glucocorticoids enhance the anti-leukemic activity of FLT3 inhibitors in FLT3 mutant acute myeloid leukemia. MT Gebru, JM Atkinson, M Young, L Zhang, Z Tang, Z Liu, P Lu, C Dower, ... Blood, 2020 | 28 | 2020 |
